Clinical Trials Browser

Phase 2 × CT-322 × CNS × Clear all

NCT00562419 2010-10-27

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

Phase 2 Unknown

Glioblastoma, Central Nervous System Neoplasms